Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior

Neuropsychopharmacology

Volumn 37, Issue 1, 2012, Pages 137-162

  Haroon, Ebrahim ^a   Raison, Charles L ^a   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; depression; immunology; mood; neuroendocrinology; neurotransmitters

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BUNGAROTOXIN RECEPTOR; C REACTIVE PROTEIN; CHEMOKINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTOXIN; ETANERCEPT; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOAMINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE; NEUROTRANSMITTER; PAROXETINE; PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN TRANSPORTER; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADRENERGIC SYSTEM; ALCOHOLISM; ASTROCYTE; BACTEROIDES FRAGILIS; BASAL GANGLION; BECK DEPRESSION INVENTORY; BIFIDOBACTERIUM LONGUM INFANTIS; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN REGION; CD4+ CD25+ T LYMPHOCYTE; CELL DENSITY; CEREBROSPINAL FLUID; CHILD ABUSE; CHOLINERGIC SYSTEM; CINGULATE GYRUS; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DEPRESSION; DIET; DNA POLYMORPHISM; DORSAL ANTERIOR CINGULATE CORTEX; DRUG TARGETING; ENZYME ACTIVATION; EPIDEMIC; FATIGUE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HEPATITIS C; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; INTESTINE FLORA; LIFESTYLE MODIFICATION; MAJOR DEPRESSION; MEDITATION; MEDITERRANEAN DIET; MENTAL STRESS; METABOLIC DISORDER; MICROGLIA; NATURAL KILLER CELL; NEOPLASM; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; OBESITY; PATIENT COMPLIANCE; PERIPHERAL INFLAMMATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSORIASIS; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; PSYCHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REM SLEEP; REVIEW; RISK REDUCTION; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; TAI CHI; TREATMENT INDICATION; VAGUS NERVE STIMULATION; WEIGHT REDUCTION; YOGA;

ANIMALS; HUMANS; INFLAMMATION; MENTAL DISORDERS; NEUROPHARMACOLOGY; PSYCHONEUROIMMUNOLOGY; PSYCHOPHARMACOLOGY;

EID: 84856111463     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.205     Document Type: Review

References (290)

1. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007). Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949. (Pubitemid 47300008)
2. Alano CC, Kauppinen TM, Valls AV, Swanson RA (2006). Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103: 9685-9690. (Pubitemid 43955885)
3. Alp NJ, Channon KM (2004). Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24: 413-420. (Pubitemid 38326132)
4. Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M (2002). Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 14: 33-38. (Pubitemid 34538830)
5. Anisman H, Merali Z, Hayley S (2008). Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85: 1-74.
6. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B et al (2007). Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861. (Pubitemid 47240944)
7. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J et al (2006). 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114: 1193-1201. (Pubitemid 44386484)
8. Arikawa AY, Thomas W, Schmitz KH, Kurzer MS (2010). Sixteen weeks of exercise reduces C-reactive protein levels in young women. Med Sci Sports Exerc 43: 1002-1009.
9. Avissar S, Nechamkin Y, Roitman G, Schreiber G (1997). Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. Am J Psychiatry 154: 211-217. (Pubitemid 27053727)
10. Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M (2011). Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 25: 397-407.
11. Bailey MT, Engler H, Sheridan JF (2006). Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol 171: 29-37. (Pubitemid 41832275)
12. Banks WA, Kastin AJ, Durham DA (1989). Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull 23: 433-437. (Pubitemid 20035305)
13. Barbour KA, Blumenthal JA (2005). Exercise training and depression in older adults. Neurobiol Aging 26(Suppl 1): 119-123.
14. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, Watkins LR, Rudy JW et al (2003). Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121: 847-853. (Pubitemid 37324583)
15. Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P et al (2010). The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67: 543-549.
16. Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J et al (2011). Angiotensin II AT(1) receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 36: 857-870.
17. Ben Menachem-Zidon O, Goshen I, Kreisel T, Ben Menahem Y, Reinhartz E, Ben Hur T et al (2008). Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 33: 2251-2262. (Pubitemid 351992082)
18. Bersano A, Aghemo A, Rumi MG, Ballabio E, Candelise L, Colombo M (2008). Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism. Eur J Intern Med 19: 370-371. (Pubitemid 351790762)
19. Besedovsky HO, del Rey A (1996). Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17: 64-102. (Pubitemid 26061368)
20. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E et al (2001). CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702-710. (Pubitemid 32595408)
21. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D et al (2003). A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 100: 1920-1925. (Pubitemid 36254549)
22. Blume J, Douglas SD, Evans DL (2011). Immune suppression and immune activation in depression. Brain Behav Immun 25: 221-229.
23. Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D et al (1994). Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317: 499-503. (Pubitemid 24220250)
24. Boissier MC, Assier E, Falgarone G, Bessis N (2008). Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 75: 373-375.
25. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M et al (2002). Increased depressive ratings in patients with hepatitis C receiving interferonalpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22: 86-90. (Pubitemid 34101297)
26. Bondolfi G, Jermann F, der Linden MV, Gex-Fabry M, Bizzini L, Rouget BW et al (2010). Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system. J Affect Disord 122: 224-231.
27. Bower JE, Ganz PA, Aziz N, Fahey JL (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64: 604-611. (Pubitemid 34791163)
28. Breder CD, Dinarello CA, Saper CB (1988). Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240: 321-324.
29. Brown DW, Anda RF, Tiemeier H, Felitti VJ, Edwards VJ, Croft JB et al (2009). Adverse childhood experiences and the risk of premature mortality. Am J Prev Med 37: 389-396.
30. Brown RP, Gerbarg PL (2005). Sudarshan Kriya Yogic breathing in the treatment of stress, anxiety, and depression. Part IIFclinical applications and guidelines. J Altern Complement Med 11: 711-717. (Pubitemid 41279088)
31. Brydon L (2011). Adiposity, leptin and stress reactivity in humans. Biol Psychol 86: 114-120.
32. Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD (2008). Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 63: 1022-1029.
33. Brynskikh A, Warren T, Zhu J, Kipnis J (2008). Adaptive immunity affects learning behavior in mice. Brain Behav Immun 22: 861-869.
34. Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C et al (2008). Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 14: 1095-1104.
35. Burton BK, Bausell H, Katz R, Laduca H, Sullivan C (2010). Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol Genet Metab 101: 110-114.
36. Cao C, Matsumura K, Yamagata K, Watanabe Y (1997). Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 272: R1712-R1725.
37. Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH (2009). Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord 119: 181-185.
38. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D et al (2003a). Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 54: 906-914. (Pubitemid 37311353)
39. Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS et al (2005). Anterior cingulate activation and error processing during interferonalpha treatment. Biol Psychiatry 58: 190-196. (Pubitemid 41112266)
40. Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B et al (2007). Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32: 2384-2392. (Pubitemid 47587675)
41. Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A et al (2010). Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation. Psychol Med 41: 1517-1528.
42. Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH (2003b). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160: 1342-1345. (Pubitemid 41070955)
43. Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P et al (2011). Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70: 175-182.
44. Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH (2010). Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 35: 2617-2623.
45. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD (1998). Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280: 747-749. (Pubitemid 28243351)
46. Chiesa A, Serretti A (2010). Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res 187: 441-453.
47. Clark J, Vagenas P, Panesar M, Cope AP (2005). What does tumour necrosis factor excess do to the immune system long term? Ann Rheum Dis 64(Suppl 4): iv70-iv76. (Pubitemid 41532024)
48. Cohen H, Ziv Y, Cardon M, Kaplan Z, Matar MA, Gidron Y et al (2006). Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol 66: 552-563.
49. Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT (2007). Social regulation of gene expression in human leukocytes. Genome Biol 8: R189.
50. Coppen A, Bailey J (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 60: 121-130.
51. Corona AW, Huang Y, O'Connor JC, Dantzer R, Kelley KW, Popovich PG et al (2010). Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation 7: 93.
52. Dai J, Jones DP, Goldberg J, Ziegler TR, Bostick RM, Wilson PW et al (2008a). Association between adherence to the Mediterranean diet and oxidative stress. Am J Clin Nutr 88: 1364-1370.
53. Dai J, Miller AH, Bremner JD, Goldberg J, Jones L, Shallenberger L et al (2008b). Adherence to the Mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation 117: 169-175.
54. Damsker JM, Hansen AM, Caspi RR (2010). Th1 and Th17 cells: adversaries and collaborators. Ann NY Acad Sci 1183: 211-221.
55. Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 65: 409-415.
56. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 104: 1319-1324. (Pubitemid 46184002)
57. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56. (Pubitemid 350295688)
58. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I et al (2009). Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62: 479-493.
59. de Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A (2010). Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res 215: 146-151.
60. Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR et al (2010). Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207: 1067-1080.
61. De Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ et al (2010). Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40: 103-110.
62. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG (2010). Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170: 1179-1188.
63. Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI et al (2009). Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res 43: 962-969.
64. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL et al (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499.
65. Di Pucchio T, Danese S, De Cristofaro R, Rutella S (2010). Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. Expert Opin Ther Pat 20: 229-250.
66. D'Mello C, Le T, Swain MG (2009). Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29: 2089-2102.
67. Dong Y, Aronsson M, Gustafsson JA, Okret S (1989). The mechanism of cAMPinduced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 264: 13679-13683. (Pubitemid 19198452)
68. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM (2000). Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 97: 11893-11898.
69. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446-457.
70. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
71. Dunn AJ, Wang J (1995). Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2: 319-328. (Pubitemid 26233179)
72. Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M et al (1999). Ligandindependent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 274: 1005-1010.
73. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T et al (1994). The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14: 783-801. (Pubitemid 24266530)
74. Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010). Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68: 748-754.
75. Eisenberger NI, Lieberman MD (2004). Why rejection hurts: a common neural alarm system for physical and social pain. Trends Cogn Sci 8: 294-300. (Pubitemid 38887445)
76. Eisenberger NI, Lieberman MD, Satpute AB (2005). Personality from a controlled processing perspective: an fMRI study of neuroticism, extraversion, and selfconsciousness. Cogn Affect Behav Neurosci 5: 169-181. (Pubitemid 44252012)
77. Engler H, Bailey MT, Engler A, Stiner-Jones LM, Quan N, Sheridan JF (2008). Interleukin-1 receptor type 1-deficient mice fail to develop social stressassociated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 33: 108-117.
78. Ericsson A, Kovacs KJ, Sawchenko PE (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897-913. (Pubitemid 24043940)
79. Fabricatore AN, Wadden TA, Higginbotham AJ, Faulconbridge LF, Nguyen AM, Heymsfield SB et al (2011). Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. Int J Obes (Lond) (e-pub ahead of print 22 February 2011).
80. Fabry Z, Fitzsimmons KM, Herlein JA, Moninger TO, Dobbs MB, Hart MN (1993). Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 47: 23-34. (Pubitemid 23274632)
81. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T (1997). Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 154: 426-428. (Pubitemid 27098298)
82. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ et al (2001). Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57: 2083-2088. (Pubitemid 33126878)
83. Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM et al (2007). Effects of interferon-alpha on Rhesus monkeys: a nonhuman primate model of cytokineinduced depression. Biol Psychiatry 62: 1324-1333. (Pubitemid 350060899)
84. Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL et al (2011). Early activation of p38 mitogen activated protein kinase is associated with interferonalpha-induced depression and fatigue. Brain Behav Immun 25: 1094-1098.
85. Fink LN (2010). Induction of regulatory T cells by probiotics: potential for treatment of allergy? Clin Exp Allergy 40: 5-8.
86. Fitzgerald P, O'Brien SM, Scully P, Rijkers K, Scott LV, Dinan TG (2006). Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med 36: 37-43. (Pubitemid 41825344)
87. Fleshner M (2011). The gut microbiota: a new player in the innate immune stress response? Brain Behav Immun 25: 395-396.
88. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF (2007). Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS proinflammatory cytokine responses. Brain Behav Immun 21: 47-59. (Pubitemid 44854445)
89. Frasure-Smith N, Lesperance F, Irwin MR, Talajic M, Pollock BG (2009). The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 23: 1140-1147.
90. Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H et al (2006). The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem 139: 655-662. (Pubitemid 43973911)
91. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B (2002). Microglial activationmediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81: 1285-1297. (Pubitemid 34809262)
92. Gilbody S, Lewis S, Lightfoot T (2007a). Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165: 1-13. (Pubitemid 46026203)
93. Gilbody S, Lightfoot T, Sheldon T (2007b). Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 61: 631-637. (Pubitemid 46998897)
94. Gimeno D, Kivimaki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A et al (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39: 413-423.
95. Ginsberg LD, Oubre AY, Daoud YA (2011). L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode. Innov Clin Neurosci 8: 19-28.
96. Godbout JP, Berg BM, Krzyszton C, Johnson RW (2005). Alpha-tocopherol attenuates NFkappaB activation and pro-inflammatory cytokine production in brain and improves recovery from lipopolysaccharide-induced sickness behavior. J Neuroimmunol 169: 97-105. (Pubitemid 41527095)
97. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M et al (1990). Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392-395. (Pubitemid 20252436)
98. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010). The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152: 346-357.
99. Grilli M, Pizzi M, Memo M, Spano P (1996). Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 1383-1385. (Pubitemid 26391464)
100. Gruol DJ, Campbell NF, Bourgeois S (1986). Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J Biol Chem 261: 4909-4914. (Pubitemid 17204279)
101. Guidetti P, Schwarcz R (2003). 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Adv Exp Med Biol 527: 137-145. (Pubitemid 38197638)
102. Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM (2005a). Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol Appl Neurobiol 31: 395-404. (Pubitemid 41059860)
103. Guillemin GJ, Meininger V, Brew BJ (2005b). Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegener Dis 2: 166-176. (Pubitemid 43827918)
104. Guillemin GJ, Smythe G, Takikawa O, Brew BJ (2005c). Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49: 15-23. (Pubitemid 40023649)
105. Habibi-Asl B, Hassanzadeh K, Charkhpour M (2009). Central administration of minocycline and riluzole prevents morphine-induced tolerance in rats. Anesth Analg 109: 936-942.
106. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A et al (1994). Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 14: 6696-6703. (Pubitemid 24299739)
107. Hamidi M, Drevets WC, Price JL (2004). Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 55: 563-569. (Pubitemid 38315029)
108. Hannestad J, DellaGioia N, Ortiz N, Pittman B, Bhagwagar Z (2011). Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun 25: 256-259.
109. Hardingham GE, Fukunaga Y, Bading H (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5: 405-414. (Pubitemid 34454245)
110. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009a). Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66: 407-414.
111. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Dolan RJ et al (2009b). Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 66: 415-422.
112. Hashimoto K, Sawa A, Iyo M (2007). Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62: 1310-1316. (Pubitemid 350060893)
113. Haske T, Nakao M, Moudgil VK (1994). Phosphorylation of immunopurified rat liver glucocorticoid receptor by the catalytic subunit of cAMP-dependent protein kinase. Mol Cell Biochem 132: 163-171. (Pubitemid 24255286)
114. Haydon PG, Carmignoto G (2006). Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86: 1009-1031. (Pubitemid 44033387)
115. Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT et al (2008). Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5: 15.
116. Himmerich H, Milenovic S, Fulda S, Plumakers B, Sheldrick AJ, Michel TM et al (2010). Regulatory T cells increased while IL-1beta decreased during antidepressant therapy. J Psychiatr Res 44: 1052-1057.
117. Hu F, Pace TW, Miller AH (2009). Interferon-alpha inhibits glucocorticoid receptormediated gene transcription via STAT5 activation in mouse HT22 cells. Brain Behav Immun 23: 455-463.
118. Huang L, Baban B, Johnson III BA, Mellor AL (2010). Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol 29: 133-155.
119. Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, Rezvani N et al (2008a). Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun 22: 1178-1189.
120. Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL et al (2008b). Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphineinduced analgesia. Brain Behav Immun 22: 1248-1256.
121. Ida T, Hara M, Nakamura Y, Kozaki S, Tsunoda S, Ihara H (2008). Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett 432: 232-236.
122. Irwin MR, Miller AH (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21: 374-383. (Pubitemid 46528684)
123. Irwin MR, Olmstead R, Valladares EM, Breen EC, Ehlers CL (2009). Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol Psychiatry 66: 191-195.
124. Ishibashi S, Maric D, Mou Y, Ohtani R, Ruetzler C, Hallenbeck JM (2009). Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab 29: 606-620.
125. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN et al (2005). Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135: 1295-1307. (Pubitemid 41416690)
126. Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU et al (2000). Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152: 383-389.
127. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics in primary prevention of atopic disease: a randomised placebocontrolled trial. Lancet 357: 1076-1079. (Pubitemid 32322538)
128. Kalliomaki M, Salminen S, Poussa T, Isolauri E (2007). Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J Allergy Clin Immunol 119: 1019-1021. (Pubitemid 46527807)
129. Kato H, Fox DA (2010). Are Th17 cells an appropriate new target in the treatment of rheumatoid arthritis? Clin Transl Sci 3: 319-326.
130. Katz JB, Muller AJ, Prendergast GC (2008). Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222: 206-221. (Pubitemid 351430372)
131. Kendler KS, Karkowski LM, Prescott CA (1999). Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156: 837-841. (Pubitemid 29260336)
132. Kiecolt-Glaser JK (2010). Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med 72: 365-369.
133. Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP (2009). Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun 381: 671-675.
134. Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M (2004). T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci USA 101: 8180-8185. (Pubitemid 38698074)
135. Kipnis J, Derecki NC, Yang C, Scrable H (2008). Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol 29: 455-463.
136. Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T (2003). Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Res 978: 104-114. (Pubitemid 36780963)
137. Komaki G, Arimura A, Koves K (1992). Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis. Am J Physiol 262: E246-E251.
138. Koo JW, Duman RS (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105: 751-756. (Pubitemid 351171780)
139. Koo JW, Duman RS (2009). Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 456: 39-43.
140. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010). Nuclear factorkappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 107: 2669-2674.
141. Kox M, Pompe JC, Gordinou de Gouberville MC, van der Hoeven JG, Hoedemaekers CW, Pickkers P (2011). Effects of the alphaalpha7nAChR agonist GTS-21 on the innate immune response in humans. Shock 36: 5-11.
142. Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M et al (2007). Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 157: 1275-1277. (Pubitemid 350115684)
143. Kumar S, Boehm J, Lee JC (2003). p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2: 717-726. (Pubitemid 37361787)
144. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379. (Pubitemid 30105765)
145. Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS et al (2011). Complementary use of Tai Chi Chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry (e-pub ahead of print).
146. Lee YK, Mazmanian SK (2010). Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330: 1768-1773.
147. Lewitus GM, Cohen H, Schwartz M (2008). Reducing post-traumatic anxiety by immunization. Brain Behav Immun 22: 1108-1114.
148. Lewitus GM, Wilf-Yarkoni A, Ziv Y, Shabat-Simon M, Gersner R, Zangen A et
149. Li W, Knowlton D, Woodward WR, Habecker BA (2003). Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 86: 774-783. (Pubitemid 36897456)
150. Li Y, Xiao B, Qiu W, Yang L, Hu B, Tian X et al (2010). Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. J Affect Disord 124: 68-75.
151. Lin PY, Huang SY, Su KP (2010). A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 68: 140-147.
152. Lin PY, Su KP (2007). A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68: 1056-1061.
153. Liu J, Gong N, Huang X, Reynolds AD, Mosley RL, Gendelman HE (2009). Neuromodulatory activities of CD4+CD25+ regulatory Tcells in a murine model of HIV-1-associated neurodegeneration. J Immunol 182: 3855-3865.
154. Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG (2009). Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 65: 344-348.
155. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64: 461-467.
156. Lu X, Ma L, Ruan L, Kong Y, Mou H, Zhang Z et al (2010). Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J Neuroinflammation 7: 46.
157. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al (2010). Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67: 220-229.
158. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E (1993). Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 150: 1189-1193. (Pubitemid 23218899)
159. Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991). Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84: 379-386.
160. Maes M, Kubera M, Leunis JC (2008). The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29: 117-124.
161. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C et al (1992a). Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22: 45-53.
162. Maes M, Scharpe S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P et al (1992b). Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24: 183-192.
163. Matute C (2011). Glutamate and ATP signalling in white matter pathology. J Anat 219: 53-64.
164. Matute C, Domercq M, Sanchez-Gomez MV (2006). Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53: 212-224.
165. Mazzeo RS, Donovan D, Fleshner M, Butterfield GE, Zamudio S, Wolfel EE et al (2001). Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade. J Appl Physiol 91: 2143-2149. (Pubitemid 33015067)
166. McKinney Jr WT, Eising RG, Moran EC, Suomi SJ, Harlow HF (1971). Effects of reserpine on the social behavior of Rhesus monkeys. Dis Nerv Syst 32: 735-741.
167. McNamara RK, Liu Y (2011). Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. J Affect Disord 129: 359-363.
168. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA (2009). Exercise for depression. Cochrane Database Syst Rev CD004366.
169. Medh RD, Saeed MF, Johnson BH, Thompson EB (1998). Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Res 58: 3684-3693. (Pubitemid 28376569)
170. Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzman M, Di Marzo V (1999). Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 463: 235-240. (Pubitemid 30001925)
171. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N (2006). Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 21: 227-231. (Pubitemid 43740300)
172. Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A et al (2002). Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 159: 746-754. (Pubitemid 34465047)
173. Meyers CA, Albitar M, Estey E (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104: 788-793. (Pubitemid 41113679)
174. Milaneschi Y, Bandinelli S, Penninx BW, Vogelzangs N, Corsi AM, Lauretani F et al (2010). Depressive symptoms and inflammation increase in a prospective study of older adults: a protective effect of a healthy (Mediterranean-style) diet. Mol Psychiatry 16: 589-590.
175. Miller AH (2008a). Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23: 149-158.
176. Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732-741.
177. Miller AH, Vogt GJ, Pearce BD (2002). The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function. Neuropsychopharmacology 27: 939-948. (Pubitemid 35447631)
178. Miller AL (2008b). The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 13: 216-226.
179. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R et al (2008). A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry 64: 266-272.
180. Mitra AK, Gao L, Zucker IH (2010). Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons. Am J Physiol Cell Physiol 299: C561-C569.
181. Molina-Hernandez M, Tellez-Alcantara NP, Perez-Garcia J, Olivera-Lopez JI, Jaramillo-Jaimes MT (2008). Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 32: 380-386. (Pubitemid 351178956)
182. Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA et al (2006). Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 24: 1852-1859. (Pubitemid 46638983)
183. Moron JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM et al (2003). Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23: 8480-8488. (Pubitemid 37158747)
184. Motivala SJ, Sarfatti A, Olmos L, Irwin MR (2005). Inflammatory markers and sleep disturbance in major depression. Psychosom Med 67: 187-194. (Pubitemid 40410952)
185. Motivala SJ, Sollers J, Thayer J, Irwin MR (2006). Tai Chi Chih acutely decreases sympathetic nervous system activity in older adults. J Gerontol A Biol Sci Med Sci 61: 1177-1180. (Pubitemid 46034469)
186. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B et al (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11: 680-684. (Pubitemid 43989814)
187. Murumkar PR, DasGupta S, Chandani SR, Giridhar R, Yadav MR (2010). Novel TACE inhibitors in drug discovery: a review of patented compounds. Expert Opin Ther Pat 20: 31-57.
188. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS et al (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344: 961-966. (Pubitemid 32240314)
189. Nadjar A, Bluthe RM, May MJ, Dantzer R, Parnet P (2005). Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30: 1492-1499. (Pubitemid 41153121)
190. Nance DM, Sanders VM (2007). Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21: 736-745. (Pubitemid 47002215)
191. Nathan C (2008). Epidemic inflammation: pondering obesity. Mol Med 14: 485-492.
192. Nathan C, Ding A (2010). Nonresolving inflammation. Cell 140: 871-882.
193. Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M et al (2008). Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9: 622-627.
194. O'Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J et al (2009). Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182: 3202-3212.
195. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N et al (2008). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522.
196. O'Mahony C, van der Kleij H, Bienenstock J, Shanahan F, O'Mahony L (2009). Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 297: R1118-R1126.
197. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295. (Pubitemid 28509564)
198. Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC (2011). CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J Neuroinflammation 8: 9.
199. Pace TW, Hu F, Miller AH (2007). Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21: 9-19. (Pubitemid 44872932)
200. Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH et al (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163: 1630-1633. (Pubitemid 44465765)
201. Pace TW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD et al (2009). Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 34: 87-98.
202. Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M (2010). S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 167: 942-948.
203. Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T et al (2004a). Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry 65: 1096-1098.
204. Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T et al (2004b). Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 65: 1090-1095.
205. Pariante CM (2004). Glucocorticoid receptor function in vitro in patients with major depression. Stress 7: 209-219. (Pubitemid 40591421)
206. Pariante CM, Lightman SL (2008). The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31: 464-468.
207. Pariante CM, Miller AH (2001). Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49: 391-404. (Pubitemid 32234301)
208. Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C et al (1999). The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140: 4359-4366. (Pubitemid 30647135)
209. Paulus MP, Feinstein JS, Simmons A, Stein MB (2004). Anterior cingulate activation in high trait anxious subjects is related to altered error processing during decision making. Biol Psychiatry 55: 1179-1187. (Pubitemid 38739452)
210. Pemberton LA, Kerr SJ, Smythe G, Brew BJ (1997). Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interferon Cytokine Res 17: 589-595. (Pubitemid 27451155)
211. Penuelas I, Encio IJ, Lopez-Moratalla N, Santiago E (1998). cAMP activates transcription of the human glucocorticoid receptor gene promoter. J Steroid Biochem Mol Biol 67: 89-94. (Pubitemid 28547098)
212. Pitt D, Nagelmeier IE, Wilson HC, Raine CS (2003). Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis. Neurology 61: 1113-1120. (Pubitemid 37461947)
213. Potter MC, Elmer GI, Bergeron R, Albuquerque EX, Guidetti P, Wu HQ et al (2010). Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 35: 1734-1742.
214. Proudfoot AE, Power CA, Schwarz MK (2010). Anti-chemokine small molecule drugs: a promising future? Expert Opin Investig Drugs 19: 345-355.
215. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
216. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS et al (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55: 453-462. (Pubitemid 46383175)
217. Quan N, Avitsur R, Stark JL, He L, Shah M, Caligiuri M et al (2001). Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol 115: 36-45. (Pubitemid 32245651)
218. Quan N, Banks WA (2007). Brain-immune communication pathways. Brain, Behavior, and Immunity 21: 727-735. (Pubitemid 47002217)
219. Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM et al (2005a). Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 66: 41-48.
220. Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ et al (2009). Activation of central nervous system inflammatory pathways by interferonalpha: relationship to monoamines and depression. Biol Psychiatry 65: 296-303.
221. Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH (2010a). Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 15: 535-547.
222. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G et al (2010b). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15: 393-403.
223. Raison CL, Demetrashvili M, Capuron L, Miller AH (2005b). Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19: 105-123. (Pubitemid 40321763)
224. Raison CL, Lowry CA, Rook GA (2010c). Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 67: 1211-1224.
225. Raison CL, Woolwine BJ, Demetrashvili MF, Borisov AS, Weinreib R, Staab JP et al (2007). Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 25: 1163-1174. (Pubitemid 46650303)
226. Rajkowska G, Miguel-Hidalgo JJ (2007). Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6: 219-233. (Pubitemid 46916253)
227. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445-452. (Pubitemid 32411324)
228. Rhen T, Cidlowski JA (2005). Antiinflammatory action of glucocorticoidsFnew mechanisms for old drugs. N Engl J Med 353: 1711-1723.
229. Ridker PM (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369. (Pubitemid 36158034)
230. Rios C, Santamaria A (1991). Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16: 1139-1143.
231. Rohrig UF, Awad L, Grosdidier A, Larrieu P, Stroobant V, Colau D et al (2010). Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem 53: 1172-1189.
232. Saeed SA, Antonacci DJ, Bloch RM (2010). Exercise, yoga, and meditation for depressive and anxiety disorders. Am Fam Physician 81: 981-986.
233. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010). FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
234. Sanchez MM, Alagbe O, Felger JC, Zhang J, Graff AE, Grand AP et al (2007). Activated p38 MAPK is associated with decreased CSF 5-HIAA and increased maternal rejection during infancy in rhesus monkeys. Mol Psychiatry 12: 895-897. (Pubitemid 47482700)
235. Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A, Schlatter J, Lahortiga F, Serra Majem L et al (2009). Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 66: 1090-1098.
236. Saxena M, Williams S, Tasken K, Mustelin T (1999). Crosstalk between cAMPdependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol 1: 305-311. (Pubitemid 129495782)
237. Schwarcz R, Pellicciari R (2002). Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303: 1-10.
238. Schwartz M, Shechter R (2010). Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry 15: 342-354.
239. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92: 994-1000. (Pubitemid 30469965)
240. Shelton RC, Hal Manier D, Lewis DA (2009). Protein kinases A and C in postmortem prefrontal cortex from persons with major depression and normal controls. Int J Neuropsychopharmacol 12: 1223-1232.
241. Shelton RC, Mainer DH, Sulser F (1996). cAMP-dependent protein kinase activity in major depression. Am J Psychiatry 153: 1037-1042. (Pubitemid 26264704)
242. Shelton RC, Miller AH (2010). Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91: 275-299.
243. Shoelson SE, Herrero L, Naaz A (2007). Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180. (Pubitemid 46693756)
244. Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, Goldstein H et al (2004). A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 10: 284-292. (Pubitemid 39429939)
245. Simen BB, Duman CH, Simen AA, Duman RS (2006). TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 59: 775-785.
246. Slavich GM, Way BM, Eisenberger NI, Taylor SE (2010). Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc Natl Acad Sci USA 107: 14817-14822.
247. Sluzewska A, Sobieska M, Rybakowski JK (1997). Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35: 123-127. (Pubitemid 27196534)
248. Smoak KA, Cidlowski JA (2004). Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev 125: 697-706. (Pubitemid 39482400)
249. Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS (2009). The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology 30: 497-521.
250. Spetsieris PG, Moeller JR, Dhawan V, Ishikawa T, Eidelberg D (1995). Visualizing the evolution of abnormal metabolic networks in the brain using PET. Comput Med Imaging Graph 19: 295-306.
251. Spiegel D, Giese-Davis J, Taylor CB, Kraemer H (2006). Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 31: 1231-1244. (Pubitemid 44792371)
252. Stahl SM (2007). Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 12: 739-744. (Pubitemid 350072170)
253. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C et al (2008). Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42: 151-157. (Pubitemid 350061255)
254. Stone TW (2001). Kynurenic acid antagonists and kynurenine pathway inhibitors. Expert Opin Investig Drugs 10: 633-645. (Pubitemid 32288182)
255. Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC et al (2010). Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 67: 550-557.
256. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O et al (2007). Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007: 76396.
257. Szuster-Ciesielska A, Slotwinska M, Stachura A, Marmurowska-Michalowska H, Dubas-Slemp H, Bojarska-Junak A et al (2008). Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32: 686-694. (Pubitemid 351312366)
258. Takahashi N, Tetsuka T, Uranishi H, Okamoto T (2002). Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur J Biochem 269: 4559-4565.
259. Tamir A, Granot Y, Isakov N (1996). Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J Immunol 157: 1514-1522. (Pubitemid 126449088)
260. Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S et al (2009). Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci USA 106: 8865-8870.
261. Teeling JL, Cunningham C, Newman TA, Perry VH (2010). The effect of nonsteroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav Immun 24: 409-419.
262. Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008). Th17 cells in human disease. Immunol Rev 223: 87-113. (Pubitemid 351986173)
263. Thayer JF, Fischer JE (2009). Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 265: 439-447.
264. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588. (Pubitemid 32298200)
265. Tikka TM, Koistinaho JE (2001). Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533. (Pubitemid 32525632)
266. Tilleux S, Hermans E (2007). Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85: 2059-2070. (Pubitemid 47172138)
267. Tracey KJ (2009). Reflex control of immunity. Nat Rev Immunol 9: 418-428.
268. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A et al (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: doubleblind placebo-controlled randomised phase III trial. Lancet 367: 29-35. (Pubitemid 43038667)
269. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS (2003). Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 14: 347-353. (Pubitemid 37282832)
270. Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM et al (2008). Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 65: 1386-1393.
271. Volgraf M, Lumb JP, Brastianos HC, Carr G, Chung MK, Munzel M et al (2008). Biomimetic synthesis of the IDO inhibitors exiguamine A and B. Nat Chem Biol 4: 535-537.
272. Volterra A, Meldolesi J (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6: 626-640. (Pubitemid 41059337)
273. Wang X, Wu H, Miller AH (2004). Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol Psychiatry 9: 65-75. (Pubitemid 38175083)
274. Watkins LR, Wiertelak EP, Goehler LE, Mooney-Heiberger K, Martinez J, Furness L et al (1994). Neurocircuitry of illness-induced hyperalgesia. Brain Res 639: 283-299. (Pubitemid 24078567)
275. Wichmann T, DeLong MR (1999). Oscillations in the basal ganglia. Nature 400: 621-622.
276. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al (2007). Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957. (Pubitemid 47300009)
277. Wolf SA, Steiner B, Akpinarli A, Kammertoens T, Nassenstein C, Braun A et al (2009). CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol 182: 3979-3984.
278. Wong ML, Dong C, Maestre-Mesa J, Licinio J (2008). Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 13: 800-812.
279. Woods JA, Vieira VJ, Keylock KT (2009). Exercise, inflammation, and innate immunity. Immunol Allergy Clin North Am 29: 381-393.
280. Wu HQ, Rassoulpour A, Schwarcz R (2007). Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm 114: 33-41. (Pubitemid 46018673)
281. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ (2003). Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 28: 1182-1185.
282. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA (2009a). Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 21: 281-285.
283. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M et al (2009b). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10: 1000-1007.
284. Zhu CB, Blakely RD, Hewlett WA (2006). The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121-2131. (Pubitemid 44413189)
285. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005). p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658. (Pubitemid 40616683)
286. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010). Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35: 2510-2520.
287. Zielasek J, Hartung HP (1996). Molecular mechanisms of microglial activation. Adv Neuroimmunol 6: 191-122.
288. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N et al (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9: 268-275. (Pubitemid 43164551)
289. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A et al (2001). The relationship of depression and stressors to immunological assays: a metaanalytic review. Brain Behav Immun 15: 199-226. (Pubitemid 33070955)
290. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM et al (2002). Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8: 625-629. (Pubitemid 34633442)